NewzPresident Trump announced in Washington on Monday the successful negotiation of pricing agreements with nine additional pharmaceutical companies. These new pacts follow previous deals established between the administration and 17 other drugmakers.
The newly participating companies are Alcon, Astellas, BeOne, BridgeBio, CSL, Sun Pharma, Kyowa Kirin, Teva, and UCB. The administration's ongoing initiative aims to secure commitments from drug manufacturers to lower prescription prices.
In-depth summary · AI, neutral